Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- Check2 days agoChange DetectedThe Tainan location entry is updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' to reflect the corrected city designation.SummaryDifference0.2%

- Check9 days agoChange DetectedNo significant changes detected in the Study Details page for NCT04811092. The content and layout appear consistent with the registered record, including trial title, study design, and eligibility criteria.SummaryDifference0.0%

- Check16 days agoChange DetectedPublications section updated: added the NEJM paper 'Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis' (N Engl J Med. 2025 Oct 23; 393(16):1599-1611). The online-ahead-of-print listing dated Sep 30, 2025 was removed.SummaryDifference0.2%

- Check23 days agoChange DetectedTwo new study sites in Cali, Valle del Cauca Department, Colombia (760032) and (760042) were added, and the previously listed Santiago de Cali sites with those postal codes were removed.SummaryDifference0.0%

- Check30 days agoChange DetectedNo significant changes detected.SummaryDifference0.1%

- Check45 days agoChange DetectedUpgrade the page from v3.1.0 to v3.2.0 and add status notices along with new PubMed publication content.SummaryDifference4%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.